Cargando…
Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities
Older adults have a higher prevalence of chronic obstructive pulmonary disease (COPD), which will likely increase substantially in the coming decades owing to aging populations and increased long-term exposure to risk factors for this disease. COPD in older adults is characterized by low-grade chron...
Autores principales: | Matera, Maria Gabriella, Hanania, Nicola A., Maniscalco, Mauro, Cazzola, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300166/ https://www.ncbi.nlm.nih.gov/pubmed/37316689 http://dx.doi.org/10.1007/s40266-023-01038-0 |
Ejemplares similares
-
Novel Anti-Inflammatory Approaches to COPD
por: Cazzola, Mario, et al.
Publicado: (2023) -
The role of combination therapy with corticosteroids and long-acting β(2)-agonists in the prevention of exacerbations in COPD
por: Cazzola, Mario, et al.
Publicado: (2006) -
New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol
por: Cazzola, Mario, et al.
Publicado: (2013) -
Pharmacological treatment and current controversies in COPD
por: Cazzola, Mario, et al.
Publicado: (2019) -
Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
por: Matera, Maria Gabriella, et al.
Publicado: (2015)